New Treatment Approach Promising For Lymphoma Patients In The Developing World

Preliminary results suggest that patients with aggressive non-Hodgkin’s lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say. At the ESMO Conference Lugano (ECLU) organized by the European Society for Medical Oncology, a group headed by Prof. Hamdy Azim from Cairo University reports that giving these patients chemotherapy every 2 weeks, rather than every 3 weeks as usual, improved treatment outcomes.

More: continued here

Filed under: Clinical Trials on July 8th, 2008